Judges try artificial intelligence tools as GPT-5 pushes into health advice

Judges are piloting ´Artificial Intelligence´ to speed legal research and case management, while GPT-5´s new guidance nudges OpenAI toward offering health advice—a risky shift.

´The Download´ highlights two developments reshaping tech and public life. First, an increasing number of judges in the united states are experimenting with generative tools to help with legal research, summarize cases and draft routine orders, driven in part by severe backlogs in many courts. The move comes after widely publicized failures: lawyers filing citations to cases that do not exist, and even a sworn testimony from a stanford professor in a deepfake case that contained hallucinations despite the witness´s expertise on misinformation.

Those incidents have exposed how machine errors can propagate inside judicial processes. Yet some judges believe that with appropriate safeguards the benefits may outweigh the risks. They envision the tools as assistants for mundane tasks, speeding workflows and freeing time for more complex judgment work. Caution remains critical: court staff and lawyers still need to verify outputs, and systems must be configured to avoid relying on machine-generated assertions as authoritative facts.

Second, OpenAI´s GPT-5 has not matched the hype of a leap toward general intelligence, but the company has quietly broadened suggestions for how people use its models. Among the more consequential shifts is explicit guidance to try the models for health-related questions. That change signals a willingness to enter a domain with real-world consequences for safety and trust. Medical advice carries risk even when provided by humans; handing more of that territory to a system prone to error raises regulatory, ethical and practical questions.

The newsletter´s roundup underscores how these technology threads connect to geopolitics and industry moves. The united states extended a tariff truce with china, european arms production is expanding amid the ukraine war, and china has warned firms away from purchasing nvidia´s H20 chips. Elsewhere, the europa clipper mission remains a reminder that public investment in science continues apace, with a scheduled jupiter arrival in 2030. Together, the items sketch a world where technological possibility and real-world fragility advance in parallel, and where oversight, verification and clarity of purpose have never been more necessary.

77

Impact Score

What you may have missed about GPT-5

OpenAI framed GPT-5 as a leap toward Artificial Intelligence that thinks like a human, but early use reveals product polish more than a technical breakthrough and fresh risks in healthcare use.

Protein architects – Biomatter

Biomatter is a next-generation enzyme design company that uses generative Artificial Intelligence to push past the limits of traditional protein engineering.

###CFCACHE###

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.

Please check your email for a Verification Code sent to . Didn't get a code? Click here to resend